Novavax, Inc. NVAX shares are trading higher Monday amid a new COVID wave and rising hospitalizations.
What To Know: According to an article by CBS News, COVID-19 hospitalization and death levels have been rising for several weeks.
The EG.5 variant makes up the largest share of new cases, with the CDC estimating it comprised 20.6% of new infections, giving it the status of the "dominant" strain in the U.S.
A new highly mutated strain known as BA.2.86 is on authorities' radar, although it's prevalence is too small to appear on CDC estimates.
COVID tests appear to work for the new variants, but if one of the strains becomes more widespread, that could change.
Furthermore, fall 2023 boosters are expected to work for new variants, but it is uncertain if BA.2.86's mutations will result in the shots being "a fairly poor match".
Related Link: Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
NVAX Price Action: Shares of NVAX were up 15.8% at $8.27 at the time of publication, according to Benzinga Pro.
Image by Triggermouse from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
